STOCK TITAN

Pulse Biosciences (NASDAQ: PLSE) CEO adds 15,000 shares in open-market buy

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

PULSE BIOSCIENCES, INC. director and Chief Executive Officer Paul A. LAVIOLETTE bought 15,000 shares of common stock in an open-market purchase on May 11, 2026 at $19.69 per share. After this transaction, he directly owns 15,846 shares of the company’s stock.

Footnotes explain the shares were acquired through the company’s at-the-market equity offering program under an Equity Distribution Agreement with TD Securities (USA) LLC, during an open trading window under the insider trading policy. His holdings also include shares purchased through the company’s Employee Stock Purchase Plan in March 2026.

Positive

  • None.

Negative

  • None.
Insider LAVIOLETTE PAUL A
Role Chief Executive Officer
Bought 15,000 shs ($295K)
Type Security Shares Price Value
Purchase Common Stock 15,000 $19.69 $295K
Holdings After Transaction: Common Stock — 15,846 shares (Direct, null)
Footnotes (1)
  1. The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws. The shares reported herein were acquired in a negotiated through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale. Includes shares purchased through the Company's Employee Stock Purchase Plan in March 2026.
Shares purchased 15,000 shares Open-market purchase on May 11, 2026
Purchase price $19.69 per share Common stock transaction on May 11, 2026
Shares owned after transaction 15,846 shares Direct ownership following May 11, 2026 purchase
Net buy shares 15,000 shares Net buying activity in this Form 4/A
open-market purchase financial
"transaction_action: "open-market purchase" for the common stock transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
at-the-market equity offering program financial
"The shares reported herein were acquired through the Company's at-the-market equity offering program"
A program that lets a company sell newly issued shares directly into the open market at whatever the current trading price is, usually through a broker, and do so gradually over time instead of all at once. Investors care because it can dilute existing ownership and put steady selling pressure on the stock price, while giving the company a flexible, on-demand way to raise cash — like adding small amounts of water to a pool rather than dumping in a bucket.
Equity Distribution Agreement financial
"program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026"
An equity distribution agreement is a formal plan between a company and financial institutions to sell newly issued shares of the company's stock to investors over a period of time. It helps the company raise money gradually, similar to filling a container with water in stages, rather than all at once. For investors, it provides an organized way to buy shares and can influence the stock's supply and price.
Employee Stock Purchase Plan financial
"Includes shares purchased through the Company's Employee Stock Purchase Plan in March 2026."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LAVIOLETTE PAUL A

(Last)(First)(Middle)
C/O PULSE BIOSCIENCES, INC.
601 BRICKELL KEY DRIVE, SUITE 1080

(Street)
MIAMI FLORIDA 33131

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PULSE BIOSCIENCES, INC. [ PLSE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
05/11/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026P(1)15,000A$19.69(2)15,846(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws.
2. The shares reported herein were acquired in a negotiated through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale.
3. Includes shares purchased through the Company's Employee Stock Purchase Plan in March 2026.
/s/ Kenneth B. Stratton, as Attorney-in-Fact05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PLSE CEO Paul A. LAVIOLETTE report?

Paul A. LAVIOLETTE reported buying 15,000 shares of Pulse Biosciences common stock. The open-market purchase occurred on May 11, 2026 at $19.69 per share, increasing his direct ownership to 15,846 shares after the transaction.

At what price did the PLSE CEO buy the 15,000 shares of common stock?

The PLSE CEO bought 15,000 common shares at $19.69 per share. This open-market purchase reflects the price paid through the company’s at-the-market equity offering program on May 11, 2026 under its insider trading policy.

How many PLSE shares does the CEO hold after this Form 4/A transaction?

After the reported purchase, the CEO holds 15,846 Pulse Biosciences shares directly. This total includes the 15,000 shares bought on May 11, 2026, plus additional shares acquired earlier, including shares from the Employee Stock Purchase Plan in March 2026.

How were the newly purchased PLSE shares acquired by the CEO?

The CEO’s 15,000 newly purchased PLSE shares were acquired through the company’s at-the-market equity offering program. The program operates under an Equity Distribution Agreement with TD Securities (USA) LLC and the trade occurred during an open trading window.

Does the PLSE CEO’s position include Employee Stock Purchase Plan shares?

Yes, the CEO’s reported holdings include shares bought through the company’s Employee Stock Purchase Plan. A footnote states that his total direct ownership figure incorporates shares acquired under the plan in March 2026, in addition to the May open-market purchase.